www.fdanews.com/articles/184129-fda-approves-shingrix-for-shingles
FDA Approves Shingrix for Shingles
October 26, 2017
The FDA approved GlaxoSmithKline’s Shingrix vaccine for treatment of shingles in adults 50 and over.
An FDA advisory committee endorsed Shingrix in September.
Shingrix is a non-live, recombinant subunit vaccine for shingles and its complications, such as postherpetic neuralgia.
Merck’s Zostavax is the only other FDA-approved shingles vaccine.